Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Holy Crap. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Frequently asked questions
What sector does Nova Mentis Life Science Corp (NMLSF) operate in?
Nova Mentis Life Science Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Nova Mentis Life Science Corp (NMLSF) current stock price?
As of the latest data, Nova Mentis Life Science Corp stock price is $0.01, with a previous close of $0.01.
What is Nova Mentis Life Science Corp (NMLSF) current market capitalization?
Nova Mentis Life Science Corp market cap is approximately 781.33 thousand.
What is Nova Mentis Life Science Corp (NMLSF) Earnings Per Share (EPS)?
The trailing EPS is -$0.02.
What is Nova Mentis Life Science Corp (NMLSF) EBITDA?
Nova Mentis Life Science Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -678.68 thousand.
Does Nova Mentis Life Science Corp (NMLSF) pay dividends?
No. Nova Mentis Life Science Corp does not pay a dividend.
What is Nova Mentis Life Science Corp (NMLSF) beta (volatility) score?
Nova Mentis Life Science Corp has a beta of -0.783, indicating lower volatility than the overall market.
